- Home
- KSS vs COLL Comparison
KSS vs COLL Comparison
Compare KSS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSS
- COLL
- Stock Information
- Founded
- KSS 1962
- COLL 2002
- Country
- KSS United States
- COLL United States
- Employees
- KSS N/A
- COLL N/A
- Industry
- KSS Department/Specialty Retail Stores
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- KSS Consumer Discretionary
- COLL Health Care
- Exchange
- KSS Nasdaq
- COLL Nasdaq
- Market Cap
- KSS 931.8M
- COLL 947.6M
- IPO Year
- KSS 1992
- COLL 2015
- Fundamental
- Price
- KSS $8.23
- COLL $29.83
- Analyst Decision
- KSS Sell
- COLL Strong Buy
- Analyst Count
- KSS 13
- COLL 4
- Target Price
- KSS $8.38
- COLL $43.75
- AVG Volume (30 Days)
- KSS 9.3M
- COLL 269.0K
- Earning Date
- KSS 05-29-2025
- COLL 08-07-2025
- Dividend Yield
- KSS 6.10%
- COLL N/A
- EPS Growth
- KSS N/A
- COLL N/A
- EPS
- KSS 1.09
- COLL 1.25
- Revenue
- KSS $16,072,000,000.00
- COLL $664,283,000.00
- Revenue This Year
- KSS N/A
- COLL $20.04
- Revenue Next Year
- KSS N/A
- COLL $3.98
- P/E Ratio
- KSS $7.53
- COLL $23.39
- Revenue Growth
- KSS N/A
- COLL 17.17
- 52 Week Low
- KSS $6.04
- COLL $23.23
- 52 Week High
- KSS $24.83
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- KSS 49.34
- COLL 55.48
- Support Level
- KSS $8.09
- COLL $29.11
- Resistance Level
- KSS $8.97
- COLL $30.22
- Average True Range (ATR)
- KSS 0.46
- COLL 0.70
- MACD
- KSS -0.06
- COLL -0.06
- Stochastic Oscillator
- KSS 17.63
- COLL 49.89
About KSS Kohl's Corporation
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.